SCHEMBL4833995

SCHEMBL4833995

Cc1cc(OCCNC(=O)[C@@H]2Cc3ccccc3N2S(=O)(=O)c2ccc(-c3ccccc3C(F)(F)F)cc2)ccc1CC(=O)O

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
FFAR4 Q5NUL3 1/20 0.39
MMP8 P22894 4/20 0.37
MMP3 P08254 2/20 0.37
MCL1 Q07820 2/20 0.36
ALDH1A1 P00352 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
FFAR1 O14842 1/20 0.35
PTGER3 P43115 1/20 0.35
CACNA1B Q00975 1/20 0.35
MAPT P10636 1/20 0.35
ADAMTS4 O75173 1/20 0.34
MMP13 P45452 1/20 0.34
ADAM17 P78536 2/20 0.34
BCL2L1 Q07817 1/20 0.34
BAK1 Q16611 1/20 0.34
MMP1 P03956 1/20 0.34
TRPA1 O75762 1/20 0.34
RORC P51449 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4833947 0.94 MMP8 (0.36) FFAR4MMP8MMP3MCL1ALDH1A1
SCHEMBL4837687 0.90 FFAR4 (0.39) FFAR4MMP8MMP3MCL1MAPT
SCHEMBL4845199 0.89 FFAR4 (0.44) FFAR4MMP8MMP3ALDH1A1NPSR1
SCHEMBL4839718 0.89 RORC (0.41) MMP8MMP3RORC
SCHEMBL4842395 0.86 FFAR4 (0.43) FFAR4MMP8MMP3ALDH1A1NPSR1
SCHEMBL4838229 0.84 PPARD (0.37) FFAR4MMP8MMP3ALDH1A1NPSR1
SCHEMBL4833234 0.84 FFAR4 (0.37) FFAR4MMP8MMP3MCL1ALDH1A1
SCHEMBL4841703 0.83 MMP8 (0.42) MMP8MMP3ALDH1A1NPSR1TRPA1
SCHEMBL4845567 0.83 FFAR4 (0.39) FFAR4MMP8MMP3TRPA1RORC
SCHEMBL4843215 0.83 RORC (0.39) MMP8MMP3ALDH1A1NPSR1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7465811-B2 Indoline compounds LABORATOIRES FOURNIER S.A. (FR) 2008-12-16 US disclosed
US-20080119465-A1 Novel Indoline Compounds LABORATORIES FOURNIER S.A. (FR) 2008-05-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080119465-A1 Novel Indoline Compounds GPR119, INSR, IRS1 FFAR4 125/4885MMP8 3968/4885MMP3 3739/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.